Literature DB >> 26690066

The international POTS registry: Evaluating the efficacy of an exercise training intervention in a community setting.

Stephen A George1, Tiffany B Bivens2, Erin J Howden3, Yasir Saleem1, M Melyn Galbreath2, Dianne Hendrickson2, Qi Fu3, Benjamin D Levine4.   

Abstract

BACKGROUND: Postural orthostatic tachycardia syndrome (POTS) affects primarily young women and impairs quality of life. We found that in a research setting, exercise training along with lifestyle intervention is effective as a nondrug therapy for POTS.
OBJECTIVE: To evaluate the efficacy of our exercise training/lifestyle intervention in POTS patients in a community environment.
METHODS: We established a POTS registry and enrolled 251 patients (86% women, aged 26 ± 11 [SD] years) through their physicians. A 3-month program involving mild- to moderate-intensity endurance training (progressing from semirecumbent to upright, 3-5 times/wk, 30-45 min/session) plus strength training was implemented along with increasing salt/water intake. The program was delivered to the physicians, who oversaw training in their patients. A 10-minute stand test was performed at the physician's office and patient quality of life was assessed using the 36-Item Short Form Health Survey.
RESULTS: One hundred and three patients completed the program. Of those that completed, 71% no longer qualified for POTS and were thus in remission. The increase in heart rate from supine to 10-minute stand was markedly lower (23 ± 14 vs. 46 ± 17 beats/min before intervention; P < .001), while patient quality of life was improved dramatically after intervention (P < .001). Of those who were followed for 6-12 months (n = 31), the effect was persistent.
CONCLUSIONS: A training/lifestyle intervention program can be implemented in a community setting with physician supervision and is effective in the treatment of POTS. It remains to be determined whether exercise can be an effective long-term treatment strategy for this condition, though patients are encouraged to maintain an active lifestyle indefinitely.
Copyright © 2016 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Exercise training; Lifestyle intervention; Orthostatic intolerance; Quality of life; Tachycardia

Mesh:

Year:  2015        PMID: 26690066     DOI: 10.1016/j.hrthm.2015.12.012

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  22 in total

1.  Effects of intermittent intravenous saline infusions in patients with medication-refractory postural tachycardia syndrome.

Authors:  Mohammed Ruzieh; Aaron Baugh; Osama Dasa; Rachel L Parker; Joseph T Perrault; Anas Renno; Beverly L Karabin; Blair Grubb
Journal:  J Interv Card Electrophysiol       Date:  2017-02-09       Impact factor: 1.900

Review 2.  Postural Orthostatic Tachycardia Syndrome: Prevalence, Pathophysiology, and Management.

Authors:  Adena Zadourian; Taylor A Doherty; Iwona Swiatkiewicz; Pam R Taub
Journal:  Drugs       Date:  2018-07       Impact factor: 9.546

3.  Postural tachycardia syndrome is not caused by deconditioning.

Authors:  Svetlana Blitshteyn; David Fries
Journal:  Pulm Circ       Date:  2016-09       Impact factor: 3.017

Review 4.  Pediatric Disorders of Orthostatic Intolerance.

Authors:  Julian M Stewart; Jeffrey R Boris; Gisela Chelimsky; Phillip R Fischer; John E Fortunato; Blair P Grubb; Geoffrey L Heyer; Imad T Jarjour; Marvin S Medow; Mohammed T Numan; Paolo T Pianosi; Wolfgang Singer; Sally Tarbell; Thomas C Chelimsky
Journal:  Pediatrics       Date:  2017-12-08       Impact factor: 7.124

Review 5.  Sinus Tachycardia: a Multidisciplinary Expert Focused Review.

Authors:  Kenneth A Mayuga; Artur Fedorowski; Fabrizio Ricci; Rakesh Gopinathannair; Jonathan Walter Dukes; Christopher Gibbons; Peter Hanna; Dan Sorajja; Mina Chung; David Benditt; Robert Sheldon; Mirna B Ayache; Hiba AbouAssi; Kalyanam Shivkumar; Blair P Grubb; Mohamed H Hamdan; Stavros Stavrakis; Tamanna Singh; Jeffrey J Goldberger; James A S Muldowney; Mark Belham; David C Kem; Cem Akin; Barbara K Bruce; Nicole E Zahka; Qi Fu; Erik H Van Iterson; Satish R Raj; Fetnat Fouad-Tarazi; David S Goldstein; Julian Stewart; Brian Olshansky
Journal:  Circ Arrhythm Electrophysiol       Date:  2022-09-08

6.  2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee.

Authors:  Ty J Gluckman; Nicole M Bhave; Larry A Allen; Eugene H Chung; Erica S Spatz; Enrico Ammirati; Aaron L Baggish; Biykem Bozkurt; William K Cornwell; Kimberly G Harmon; Jonathan H Kim; Anuradha Lala; Benjamin D Levine; Matthew W Martinez; Oyere Onuma; Dermot Phelan; Valentina O Puntmann; Saurabh Rajpal; Pam R Taub; Amanda K Verma
Journal:  J Am Coll Cardiol       Date:  2022-03-16       Impact factor: 27.203

Review 7.  Pathophysiology of Noncardiac Syncope in Athletes.

Authors:  Georgios A Christou; Konstantinos A Christou; Dimitrios N Kiortsis
Journal:  Sports Med       Date:  2018-07       Impact factor: 11.136

Review 8.  Exercise and non-pharmacological treatment of POTS.

Authors:  Qi Fu; Benjamin D Levine
Journal:  Auton Neurosci       Date:  2018-07-04       Impact factor: 3.145

9.  Dysautonomia in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders is associated with exercise intolerance and cardiac atrophy.

Authors:  Tania Ruiz Maya; Veronica Fettig; Lakshmi Mehta; Bruce D Gelb; Amy R Kontorovich
Journal:  Am J Med Genet A       Date:  2021-07-30       Impact factor: 2.802

10.  Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1.

Authors:  Steven Vernino; Kate M Bourne; Lauren E Stiles; Blair P Grubb; Artur Fedorowski; Julian M Stewart; Amy C Arnold; Laura A Pace; Jonas Axelsson; Jeffrey R Boris; Jeffrey P Moak; Brent P Goodman; Kamal R Chémali; Tae H Chung; David S Goldstein; Andre Diedrich; Mitchell G Miglis; Melissa M Cortez; Amanda J Miller; Roy Freeman; Italo Biaggioni; Peter C Rowe; Robert S Sheldon; Cyndya A Shibao; David M Systrom; Glen A Cook; Taylor A Doherty; Hasan I Abdallah; Anil Darbari; Satish R Raj
Journal:  Auton Neurosci       Date:  2021-06-05       Impact factor: 2.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.